I think so, if VIT can make the process seamless for both the HCP and the patient then there is still growth in market share to be had alongside the organic growth they'll get from increasing patient numbers in Aus. Looking at their roadmap I would say they are on the right track.
There are only two companies I would park my money in at the moment in this space. One is definitely VIT, however I currently have everything parked in the other one (ECS). Not entirely apples to apples though, VIT's strength is it's tech platform and distribution network while ECS is it's ability to cultivate at a ridiculously low cost (AUD 20c per gram).
- Forums
- ASX - By Stock
- VIT
- Ann: Vitura Health joining S&P/ASX All Ordinaries Index
Ann: Vitura Health joining S&P/ASX All Ordinaries Index, page-41
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.5¢ |
Change
-0.001(1.04%) |
Mkt cap ! $55.28M |
Open | High | Low | Value | Volume |
9.6¢ | 10.0¢ | 9.5¢ | $9.793K | 99.26K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 18725 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 139232 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 18725 | 0.095 |
3 | 30354 | 0.094 |
1 | 11077 | 0.090 |
1 | 76000 | 0.089 |
3 | 25978 | 0.088 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 139232 | 7 |
0.110 | 94415 | 2 |
0.120 | 20000 | 2 |
0.125 | 256885 | 4 |
0.130 | 140869 | 2 |
Last trade - 11.26am 12/07/2024 (20 minute delay) ? |
Featured News
VIT (ASX) Chart |